Jyothy Labs to hold 35th AGM on July 14, 2026, to approve FY26 results and final dividend.
Jyothy Labs will hold its 35th AGM on July 14, 2026, via VC/OAVM. The meeting will approve audited financial statements for FY2025-26 and declare a final dividend of ₹3.50 per equity share. Directors Mr. Ravi Razdan and Independent Director Mr. Aditya Sapru are up for re-appointment. Remuneration for Cost Auditors and commission for non-executive directors will also be considered.
The announcement is about the upcoming AGM, which is a standard corporate event. The details, such as dividend declaration and director re-appointments, are typical and do not represent a significant deviation or a major strategic shift for the company.
The announcement is a routine procedural update regarding the Annual General Meeting and does not contain any new financial performance data or significant strategic changes that would positively or negatively impact the company's valuation.
Jyothy Labs Limited has announced the convening of its 35th Annual General Meeting (AGM) on Tuesday, July 14, 2026, at 11:30 A.M. IST. The meeting will be conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM) in accordance with the circulars issued by the Ministry of Corporate Affairs and SEBI.
The AGM will consider and adopt the Audited Financial Statements for the Financial Year ended March 31, 2026, including the Balance Sheet, Statement of Profit & Loss, and Cash Flow Statement. A key agenda item is the declaration of a final dividend of ₹3.50 per equity share of face value ₹1 each for the Financial Year 2025-26.
Further, the meeting will address the re-appointment of Mr. Ravi Razdan as a Director who retires by rotation and is eligible for re-appointment. Additionally, the company seeks to re-appoint Mr. Aditya Sapru as an Independent Director for a second term of five years, commencing March 28, 2027. The remuneration for the Cost Auditors for the financial year ending March 31, 2027, will also be ratified.
Shareholders will also vote on a special resolution to approve the annual payment of remuneration by way of commission to Directors (excluding Chairperson and Managing Director/Whole-time Directors) for a period of five years from April 1, 2027, not exceeding 1% of the net profits. The notice and annual report for FY2025-26 will be sent only in electronic mode to shareholders whose email IDs are registered.
What to do with a filing like this
Jyothy Labs Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jyothy Labs Limited. Read the original for the full detail.